Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EFAI RTSuite CT HN-Segmentation System

K-Number: K220264 · 2022-04-28

Decision Date2022-04-28
Product CodeQKB
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

EFAI RTSuite CT HN-Segmentation System is a medical device manufactured by Ever Fortune.Ai, Co., Ltd.. It received FDA 510(k) clearance on 2022-04-28 under approval number K220264. The device is classified under product code QKB. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EFAI RTSuite CT HN-Segmentation System?

EFAI RTSuite CT HN-Segmentation System is a medical device that received FDA 510(k) clearance on 2022-04-28. It is manufactured by Ever Fortune.Ai, Co., Ltd.. The 510(k) number is K220264.

When was EFAI RTSuite CT HN-Segmentation System approved by the FDA?

EFAI RTSuite CT HN-Segmentation System received FDA 510(k) clearance on 2022-04-28, under approval number K220264.

What company makes EFAI RTSuite CT HN-Segmentation System?

EFAI RTSuite CT HN-Segmentation System is manufactured by Ever Fortune.Ai, Co., Ltd..

What is the FDA product code for EFAI RTSuite CT HN-Segmentation System?

The FDA product code for EFAI RTSuite CT HN-Segmentation System is QKB.

Other Devices by Ever Fortune.Ai, Co., Ltd.

View all 15 devices →

Related Devices (Code: QKB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.